These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. Hashimura E; Shimizu F; Nishino T; Imagawa K; Tateishi K; Hamaoka T J Immunol Methods; 1982 Dec; 55(3):375-87. PubMed ID: 6300248 [TBL] [Abstract][Full Text] [Related]
4. The molecular nature of cholecystokinin in plasma. An in vivo immunosorption study in rabbits. Rehfeld JF Scand J Gastroenterol; 1994 Feb; 29(2):110-21. PubMed ID: 8171278 [TBL] [Abstract][Full Text] [Related]
6. Accurate measurement of cholecystokinin in plasma. Rehfeld JF Clin Chem; 1998 May; 44(5):991-1001. PubMed ID: 9590372 [TBL] [Abstract][Full Text] [Related]
7. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels. Jansen JB; Lamers CB J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353 [TBL] [Abstract][Full Text] [Related]
9. The reactivity of mononucleotides with cholecystokinin/gastrin antisera. Rehfeld JF Regul Pept; 1983 Apr; 6(1):33-41. PubMed ID: 6867379 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay of cholecystokinin: comparison of different tracers. Cantor P; Rehfeld JF J Immunol Methods; 1985 Sep; 82(1):47-55. PubMed ID: 2411820 [TBL] [Abstract][Full Text] [Related]
11. Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man. Burhol PG; Jenssen TG; Lygren I; Schulz TB; Jorde R; Waldum HL Digestion; 1982; 23(3):156-68. PubMed ID: 7106417 [TBL] [Abstract][Full Text] [Related]
12. Development of a sensitive and specific assay system for cholecystokinin tetrapeptide. Merani S; Palmour RM; Bradwejn J; Berezowska I; Vaccarino FJ; Gutkowska J Peptides; 1997; 18(6):869-75. PubMed ID: 9285937 [TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin in pig plasma: release of components devoid of a bioactive COOH-terminus. Cantor P; Rehfeld JF Am J Physiol; 1989 Jan; 256(1 Pt 1):G53-61. PubMed ID: 2912150 [TBL] [Abstract][Full Text] [Related]
14. Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study. Eysselein VE; Eberlein GA; Hesse WH; Schaeffer M; Grandt D; Williams R; Goebell H; Reeve JR Am J Physiol; 1990 Jun; 258(6 Pt 1):G951-7. PubMed ID: 2360639 [TBL] [Abstract][Full Text] [Related]
16. Molecular forms of cholecystokinin in human plasma during infusion of bombesin. Jansen JB; Lamers CB Life Sci; 1983 Nov; 33(22):2197-205. PubMed ID: 6645797 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of cholecystokinin in human tissue and plasma. Jansen JB; Lamers CB Clin Chim Acta; 1983 Jul; 131(3):305-16. PubMed ID: 6883724 [TBL] [Abstract][Full Text] [Related]
18. Large molecular forms of cholecystokinin circulating in humans. Gaisano HY; Reilly W; Go VL; Olivero D; Miller LJ Pancreas; 1986; 1(2):148-53. PubMed ID: 2437562 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a radioimmunoassay for cholecystokinin in human plasma. Cantor P Scand J Clin Lab Invest; 1986 May; 46(3):213-21. PubMed ID: 2424076 [TBL] [Abstract][Full Text] [Related]
20. Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay. Himeno S; Tarui S; Kanayama S; Kuroshima T; Shinomura Y; Hayashi C; Tateishi K; Imagawa K; Hashimura E; Hamaoka T Am J Gastroenterol; 1983 Nov; 78(11):703-7. PubMed ID: 6637957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]